COVID-19 information seeking pattern and perceived benefits in Nigeria: a cross-sectional survey

Abstract

Introduction access to COVID-19 related information is fundamental to making accurate decisions and performing evidence-based actions aimed to control its spread and improve health. This study assessed pattern and perceived benefits of COVID-19 related information in Nigeria. Methods a descriptive cross-sectional survey was carried out among adult Nigerian residents aged 18-years and above in the geopolitical zones using multistage sampling strategy. Questionnaire developed by World Health Organization (WHO) was adapted and pretested. Descriptive statistics were carried on the data and presented in frequencies, percentages, mean and standard deviation. Inferential statistics (Chi-square) was used to test differences between some categorical variables. Data obtained were analysed using statistical package for the social sciences (SPSS) software version 22. Results from responses, 498 (47.9%) of participants highly desired information on COVID-19, while 311 (29.9%) frequently sought COVID-19 information. Majority 647 (62.3%) were interested in getting information on treatment protocols/home remedies for COVID-19 prevention. Also, 934 (89.9%) found information on COVID-19 beneficial. A significant difference existed between male and female respondents regarding government guidelines on public interaction (p=0.026) and home remedies to prevent COVID-19 infection (p=0.013). Consistently, more urban residents than rural sought information on majority of the COVID-19 related information. Conclusion information on COVID-19 is highly sought by Nigerian residents and such should be widely disseminated regularly through authentic and verified social media channels. Nigerians are highly desirous of information on treatment protocols and home remedies to prevent COVID-19. Adequate provision of accurate and timely information by authorities through trusted sources will improve health literacy and help curb the spread of COVID-19.